The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

If you’re in pain and you’re looking for relief in the form of an over-the-counter drug, you’ve got a slew of options.

Suzetrigine selectively inhibits the NaV1.8 pain-signaling pathway in the peripheral nervous system and provides effective ...

Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new sophistication. The management of chronic pain in general is now being broadly ...

( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...

A large proportion of babies born very early need intensive care, which can be painful. But the healthcare system fails to provide pain relief to the full extent. This is shown by the largest survey ...

Pain management is a chronic issue that plagues the Appalachian mountains – from pharmaceutical companies rolling out ...

Samaritan Medical Center has announced that its Pain Management Center will close its door at the end of next month. In an ...

The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.

The is open to all ages of people who live with chronic pain for whatever reason and are seeking consistent ways to manage ...